Thomas J. Weber, MD is an Associate Professor of Medicine at Duke University Medical Center, where he is Medical Director of the Duke Clinical Bone Laboratory, and a Clinical Investigator in the Clinical Research Training Program of the Duke University School of Medicine. He is also a permanent member of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA, and a member of the Peer Review Committee for the Endocrine Society Self-Assessment Program (ESAP).
Dr. Weber has also authored the chapters on “Osteoporosis” and “Approach to the Patient with Metabolic Bone Disease” in the 25th and 26th editions of Cecil’s Textbook of Medicine. Dr. Weber attended the University of Chicago-Pritzker medical school, and thereafter completed his internship and residency training in Internal Medicine at Yale-New Haven Hospital and a research fellowship in Endocrinology at Duke University Medical Center.
His research focuses on metabolic bone disease more broadly, including the hypophosphatemic, osteomalacic disorders X-linked hypophosphatemic rickets (XLH) and tumor-induced osteomalacia, as well as clinical and translational studies of osteoporosis and primary hyperparathyroidism.